BNP Paribas Financial Markets Has $10.48 Million Stake in Oscar Health, Inc. $OSCR

BNP Paribas Financial Markets increased its position in Oscar Health, Inc. (NYSE:OSCR) by 1,016.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 728,920 shares of the company’s stock after purchasing an additional 663,659 shares during the period. BNP Paribas Financial Markets’ holdings in Oscar Health were worth $10,475,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in shares of Oscar Health by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock valued at $297,477,000 after buying an additional 540,851 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH boosted its stake in shares of Oscar Health by 1,097.8% during the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock valued at $3,418,000 after buying an additional 218,022 shares during the period. Farallon Capital Management LLC boosted its stake in shares of Oscar Health by 146.5% during the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock valued at $68,886,000 after buying an additional 2,163,000 shares during the period. Fred Alger Management LLC boosted its stake in shares of Oscar Health by 225.6% during the 3rd quarter. Fred Alger Management LLC now owns 1,212,383 shares of the company’s stock valued at $22,950,000 after buying an additional 840,038 shares during the period. Finally, SG Americas Securities LLC boosted its stake in shares of Oscar Health by 886.8% during the 4th quarter. SG Americas Securities LLC now owns 921,288 shares of the company’s stock valued at $13,239,000 after buying an additional 827,929 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Stock Up 11.7%

Oscar Health stock opened at $27.37 on Tuesday. The company has a market capitalization of $8.25 billion, a P/E ratio of -46.39, a P/E/G ratio of 1.71 and a beta of 2.37. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $27.59. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The firm’s fifty day simple moving average is $18.70 and its 200-day simple moving average is $16.16.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $1.11 by $0.96. The firm had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business’s quarterly revenue was up 52.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.92 EPS. Sell-side analysts forecast that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on OSCR shares. Robert W. Baird lifted their target price on shares of Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Zacks Research upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. Wall Street Zen downgraded shares of Oscar Health from a “strong-buy” rating to a “buy” rating in a report on Saturday. Wolfe Research initiated coverage on shares of Oscar Health in a report on Tuesday, May 5th. They set a “peer perform” rating on the stock. Finally, Wells Fargo & Company set a $20.00 price target on shares of Oscar Health and gave the company an “equal weight” rating in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $20.22.

Insider Transactions at Oscar Health

In other news, CEO Mark T. Bertolini bought 1,000,000 shares of the company’s stock in a transaction that occurred on Monday, April 6th. The shares were purchased at an average price of $11.92 per share, for a total transaction of $11,920,000.00. Following the acquisition, the chief executive officer directly owned 10,196,876 shares of the company’s stock, valued at $121,546,761.92. The trade was a 10.87% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Adam Mcananey sold 9,859 shares of Oscar Health stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares in the company, valued at $4,785,026.24. This trade represents a 4.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 189,660 shares of company stock worth $4,283,140. Corporate insiders own 25.11% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.